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doi:10.1016/j.jtcvs.2003.12.0081158 The Journal of Thoracic and CardObjective: This study explores the relative early and late mortality risks in women
and men after coronary artery bypass graft surgery.
Methods: This was a retrospective cohort study (n  54,425 patients, 12,079
women) using clinical data for all patients who underwent isolated coronary artery
bypass graft surgery in Ontario between fiscal years 1991 and 1999 obtained from
the Cardiac Care Network database, with outcomes of early (1 year) and late (1
year up to 10 years) interval mortality identified through linkage to administrative
databases.
Results: Female surgical candidates were older (65 vs 62 years, P  .0001) and
higher-risk patients. The risk-adjusted survival of female patients was worse than
that of male patients in the first year after coronary artery bypass graft surgery, but
their long-term mortality was similar to that of male patients. The Cox proportional
hazards model for early mortality had an adjusted female hazard ratio of 1.44 (95%
confidence interval, 1.29-1.61; P  .02). This significantly differed from the late
mortality model, which had a hazard ratio of 0.89 (95% confidence interval,
0.78-1.0; P  .06).
Conclusions: Early mortality was significantly higher for women after coronary
artery bypass graft surgery, despite adjustment for confounding factors. However,
the long-term relative mortality risk for women appeared equivalent to or even
better than that experienced by men as early as 1 year after coronary artery bypass
graft surgery. This population-based study of long-term mortality supports the
benefits of coronary artery bypass graft surgery for women in the current era.
However, further research is needed to identify ways to reduce early postoperative
mortality in women.
Early mortality (in-hospital or 30-day mortality) for women aftercoronary artery bypass graft (CABG) surgery has been shown to begreater than that of men.1-6 However, some conflicting studies reportthat early mortality among women is equivalent to that amongmen.4,6-9 Published odds for early mortality among female patientshave ranged between 1 to 2.5 times that experienced by male
patients.1-6,10 The majority of these studies have been retrospective in nature, most
from single institutions.4,6-8,10-15 There is some evidence to suggest that with
improved surgical techniques in the current era, the early mortality gap between men
and women is narrowing.16
This difference in mortality has been explained by the fact that female CABG
surgery candidates frequently present with older age, smaller body size, smaller
coronary arteries, more urgent status, and more comorbid factors than their male
counterparts.1,2,9,11,17 The difference in outcomes experienced by women after
CABG surgery could also be related to delayed referral or a different pathogenesis
8,18,19of the progression in coronary atherosclerosis. It is also not clear whether graft
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women are less likely to receive internal thoracic artery
(ITA) grafts because of small ITA size, as well as concerns
with sternal healing.2,6 Women are less likely to receive
complete revascularization, and this might be in part be-
cause of their smaller coronary artery size and pattern of
disease.6 This all greatly affects their early mortality, even
with extensive risk adjustment, and likely also has a signif-
icant effect on their late mortality after CABG surgery.
There is less known about the long-term result after
coronary surgery in women. There is some evidence to
suggest that between 5 and 6 years after CABG surgery, the
results are the same or might be better for female patients,
with odds ratios (ORs) for late death of between 0.4 and 1
as compared to male patients.7,10,14,15,21-23 This is demon-
strated by a population-based study from the city of Stock-
holm in Sweden involving 2 institutions with 607 women
and 3326 men, which revealed the 5-year mortality risk to
be equivalent between sexes for patients operated on be-
tween 1980 and 1989.15 The reason behind the trend toward
improved long-term survival for women compared with
men is not known. It might simply be a result of the fact that
women have a later onset of their cardiovascular disease and
survive longer in the general population. The original stud-
ies that demonstrated the long-term benefits of CABG sur-
gery, namely the Coronary Artery Surgery Study and By-
pass Angioplasty Revascularization Investigation had only a
minority of women. These studies were conducted in a
previous era with highly selected patients who are not
representative of the current population of patients under-
going CABG. Unfortunately, the evidence behind the long-
term survival benefits of CABG surgery for women is not as
robust as it is for men.1,22
The purpose of this study is to evaluate mortality be-
tween women and men both early and late after CABG
surgery by using large population-based clinical and admin-
istrative databases in the province of Ontario.
Methods
Study Population
This was a retrospective cohort study (n  54,425 patients) of all
patients who underwent isolated CABG surgery (without concom-
itant valve surgery) in Ontario between September 1, 1991, and
March 31, 2000, obtained from the Cardiac Care Network (CCN)
of the Ontario database. The CCN data are collected by nurses for
waiting list management of patients for cardiac surgery in the
province of Ontario according to their clinical characteristics.
There is a biannual chart audit of the CCN database with a data
accuracy rate of greater than 95%. The core covariates recognized
in the literature for risk adjustment of mortality are available
through this database.24
Data Linkage
The patients were linked to 3 administrative databases for further
clinical information by using unique encrypted identifiers, such as
The Journal of Thoracicin-hospital and out-of-hospital death. The 3 databases included the
Canadian Institute for Health Information database, the Registered
Persons Database, and the Ontario Health Insurance Plan database.
The Registered Persons Database registers the deaths of all persons
residing in Ontario and has been validated against the Canadian
Institute for Health Information database for in-hospital deaths.
The Ontario Health Insurance Plan database includes the claims
submitted by all cardiac surgeons for reimbursement for provided
services. Socioeconomic status was determined from linkage of the
postal code of each patient (Enumeration Area) to the 1996 Ca-
nadian Census database by which each patient’s income quintile is
designated on the basis of their primary residence. For patients
who did not have a Canadian postal code listed, these data were not
available. Data for 1991 were only available from September 1
onward but otherwise were analyzed on a fiscal year basis (April
1 of the year to March 31 of the subsequent year).
Data Analysis
Separate prediction models for male and female sex and early and
late mortality were constructed to identify any obvious covariate
interactions. The primary outcomes assessed included early inter-
val mortality (30 days to 1 year) and late interval mortality at
different time points (1 year to 10 years). A Kaplan-Meier curve
was constructed by sex for the entire cohort to describe mortality
after CABG surgery. A Kaplan-Meier curve was also constructed
by sex for comparison with an age-matched sample of the general
population.
Cox proportional hazards models were used to adjust mortality
for men and women for the entire cohort by using tailored risk
adjustment with previously validated variables.24,25 The variables
included in the risk adjustment models were as follows: age,
Charlson comorbidity score, urgency status, previous CABG sur-
gery, congestive heart failure, left ventricular grade, era of oper-
ation, recent preoperative myocardial infarction, previous CABG
surgery, history of preoperative stroke, peripheral vascular disease,
and surgical coronary artery anatomy. The assumption of propor-
tionality for Cox hazards analysis was tested by using a sex versus
duration to death or follow-up time covariate. Because this as-
sumption was violated, separate early mortality (1 year) and late
mortality (1 year) Cox models were created. The late mortality
model was created on the cohort described, excluding those pa-
tients who died before or at 1 year after the operation. Other
variables added to the risk-adjustment model included use of an
ITA, socioeconomic status (available for n  53,702), and body
surface area (BSA; available for subgroup of cohort [1998-1999],
n  13,921). Risk-adjusted survival curves were constructed by
sex.
Stepwise logistic regression models were developed to deter-
mine the risk-adjusted OR for female interval mortality at various
time points (30 days, 31 days to 1 year, 1 year to 2 years, 2
years to 4 years,4 years to 8 years, and8 years to 10 years) by
using subgroups of patients who survived to this time point and
who had similar follow-up, depending on their operative date.
Through this method, we were able to isolate the time point at
which the mortality risk for female sex changed from the early to
late time periods after the operation. Lack-of-fit statistics were
optimized for all logistic models constructed, including the c
statistic (area under the receiver operator curve) and the Hosmer-
and Cardiovascular Surgery ● Volume 127, Number 4 1159
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the models. The c statistic is as follows for each logistic mortality
model: 30 days, 0.78; 1 year, 0.77; 2 years, 0.70; 4 years, 0.69; 8
years, 0.71; and 10 years, 0.72. The adjusted 30-day death rates for
each sex by fiscal year, left ventricular grade, triage status, Cana-
dian Cardiovascular Society (CCS) angina class, and age were also
analyzed. These adjusted mortality rates (in percentages) were
calculated by multiplying the observed to expected death ratio by
the average death rate in the cohort for various subgroups. The
expected death was calculated by using 30-day mortality logistic
regression models (excluding the variable being compared). The
statistical analyses were completed with SAS software (version
8.2; SAS Institute Inc, Cary, NC).
Results
Patient Population
A total of 54,425 patients were operated on during the study
period, including 12,079 (22%) female patients and 42,246
(78%) male patients. The proportion of female patients
undergoing CABG surgery increased slightly from 21% in
1991 to 23% in 1999 (P  .01, Figure 1). Compared with
men, women were older and more likely to possess a
comorbid condition (Table 1).26 Women were more likely
to present with congestive heart failure, urgent or emer-
gency triage status, Canadian Cardiovascular Angina class
III or IV, or a recent myocardial infarction (Table 1).
Female patients had a lower proportion of surgically signif-
icant coronary artery disease compared with male patients
(Table 1). Female patients were less likely (70%) then male
patients to receive at least one arterial bypass (79%).
Early Results
The crude 30-day mortality rates of female patients were
higher compared with those of male patients regardless of
the year in which the operation was completed, and this
Figure 1. Percentage of female patients undergoing isdifference remained true with risk adjustment (Figures 2
1160 The Journal of Thoracic and Cardiovascular Surgery ● Aprand 3). However, both the crude and risk-adjusted 30-day
mortalities decreased over time for both sexes (Figures 2
and 3). For female patients, the risk-adjusted 30-day mor-
tality decreased from 4.7% in 1991 to 2.1% in 1999. For
male patients, the risk-adjusted 30-day mortality decreased
from 4.1% in 1991 to 1.7% in 1999. Risk-adjusted 30-day
mortality by sex and high-risk subgroups, including age,
CCS angina class, and left ventricular grade, demonstrated
a higher mortality in women in all categories. The largest
gaps in mortalities between sexes were for women aged 80
years or older with CCS class 4c angina (defined as unstable
angina with symptoms refractory to treatment or hemody-
namic instability) or left ventricular grade 3 or 4 (Table 2).
These data show that the risk-adjusted 30-day mortality for
women has remained higher than that for men in our cohort.
Late Results
The Kaplan-Meier crude survival curve showed that female
patients had a worse early and late survival after CABG
surgery (Figure 4). The survival curves of a random sample
of age-matched Ontario residents by sex during the same
time period demonstrated that women have an improved
long-term survival compared with that of men (Figure 4). It
is important to note that this survival curve from the general
population is not risk adjusted to the CABG surgery cohort.
The risk-adjusted survival curve demonstrated that the
absolute survival rate for men and women became equiva-
lent at 4 years after the operation, as seen by the overlapping
curves at this time point (Figure 5). Two Cox proportional
hazard models were constructed for 2 separate cohorts de-
fined by whether death occurred in the interval from 0 to
365 days after the operation inclusive (female hazard ratio
[HR], 1.44; 95% confidence interval [CI], 1.29-1.61; P 
d CABG surgery in Ontario by fiscal year (1991-1999)..02) or if death occurred after 365 days (female HR, 0.89;
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in these different time intervals. Thus, female sex conferred
an increased risk of death within the first year following
surgery and no longer was predictive of death at beyond 1
year after the operation.
This was confirmed and further described through risk-
adjusted ORs by using logistic regression for interval mor-
tality at various time points (Figure 6). It was found that the
30-day mortality of female patients was greater than that of
male patients (OR, 1.45; 95% CI, 1.23-1.63; P  .01). This
negative effect of female sex on mortality risk became
TABLE 1. Clinical characteristics of patients undergoing
54,425)
Male patients
Age (y) 62
Charlson comorbidity score 0.73
Chronic obstructive pulmonary disease 8.
Cerebrovascular disease 6.
Diabetes 21.
Dialysis 0.
Peripheral vascular disease 8.
Congestive heart failure 8.
Urgent or emergency triage status 46.
Canadian Cardiovascular Class III or IV 80.
Recent myocardial infarction (within 30 d) 15.
Left main coronary artery disease 17.
Significant coronary artery disease* 82.
Grade 3 or 4 left ventricular grade 23.
Previous CABG surgery 5.
The Charlson comorbidity score was calculated as previously described.2
Canadian Cardiovascular Class III angina is defined as patients with a m
Cardiovascular Class IV angina includes all patients admitted to the hosp
*Significant coronary artery disease is defined by either left main, 2-ve
triple-vessel coronary artery disease.
Figure 2. Crude 30-day mortalities for patients undergo
fiscal year.equivalent to that of male sex from 1 year on after CABG
The Journal of Thoracicsurgery as follows: greater than 30 days to 1 year (OR, 0.96;
95% CI, 0.82-1.11; P  .57), greater than 1 to 2 years (OR,
0.90; 95% CI, 0.76-1.07; P  .25), greater than 2 to 4 years
(OR, 0.89; 95% CI, 0.78-1.02; P  .10), greater than 4 to 8
years (OR, 0.91; 95% CI, 0.78-1.07; P  .27), and greater
than 8 to 10 years (OR, 0.91; 95% CI, 0.63-1.32; P  .62)
. This sensitivity analysis confirmed the results of the above
Cox model.
Further risk-adjustment factors were added to the early
and late Cox models to understand their effects on sex-
based mortality. Income quintile adjustment decreased the
G surgery in Ontario in the years 1991 through 1999 (n 
42,246) Female patients (n  12,079) P value
65 9 .0001
0.83 0.95 .0001
8.8% .003
8.2% .0001
29.3% .0001
0.9% .0001
9.1% .0001
12.5% .0001
53.6% .0001
88.5% .0001
18.1% .0001
16.7% .003
78.0% .0001
18.9% .0001
2.8% .0001
G, Coronary artery bypass graft.
limitation of their ordinary physical activity caused by angina. Canadian
ith unstable angina.
oronary artery disease with left anterior descending artery disease or
olated CABG surgery in Ontario (1991-1999) by sex andCAB
(n 
10
0.9
0%
4%
4%
7%
0%
3%
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5%
3%
9%
0%
7%
5%
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ital w
ssel cing is1-year mortality risk of female sex to an HR of 1.19 (95%
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was significantly lower than male sex risk after adjustment
for income quintile (HR, 0.94; 95% CI, 0.884-0.998; P 
.04). ITA use was a significant predictor of both early
survival (HR, 0.64; 95% CI, 0.59-0.70; P  .0001) and late
survival (HR, 0.79; 95% CI, 0.74-0.83; P  .0001) but did
not change the female sex risk on mortality. BSA data were
available in a limited available sample of patients (n 
13,921, with 3172 female patients). Adjustment for BSA
eliminated female sex as a risk factor for 30-day mortality
(HR, 1.04; 95% CI, 0.84-1.30; P  .72) but did not change
the late (1 to 10 years) mortality risk for female patients
(HR, 1.05; 95% CI, 0.83-1.31; P  .70). These additional
variables used in adjustment in subcohorts were able to
eliminate female sex as a predictor of early mortality.
Discussion
We performed a retrospective population-based study of
patients undergoing isolated CABG surgery in Ontario be-
tween 1991 and 1999 that provides insights regarding post-
operative time-dependent mortality for female patients com-
pared with male patients.
Women tend to be higher-risk operative candidates, and
this difference in mortality is larger for those female pa-
tients who were elderly or had unstable symptoms. The
risk-adjusted OR for mortality among female patients is no
different than one at 1 year after CABG surgery and remains
this way until 10 years after the operation. At 4 years after
the operation, the absolute mortality rate for female patients
becomes similar to that for male patients, as seen by over-
lapping risk-adjusted survival curves (Figure 4). The crude
survival for both sexes after CABG surgery was worse than
that of the age-matched general population. Female patients
undergoing CABG had a much larger disparity than their
male counterparts to age-matched control subjects both for
rgoing isolated CABG surgery in Ontario (1991-1999) byFigure 3. Risk-adjusted 30-day mortalities for patients undeTABLE 2. Risk-adjusted 30-day mortality after CABG sur-
gery in Ontario from 1991 through 1999 by sex for high-risk
subgroups (n  54,425)
Male patients
(n  42,246)
Female patients
(n  12,079)
Age 50 y 0.50 (0.29-0.70) 0.79 (0.34-1.24)
Age 50-59 y 0.83 (0.66-1.01) 1.42 (1.05-1.79)
Age 60-69 y 1.81 (1.60-2.03) 2.55 (2.17-2.94)
Age 70-79 y 5.83 (5.34-6.31) 7.03 (6.30-7.75)
Age 80 y 9.55 (6.87-12.24) 17.59 (13.85-21.33)
Left ventricular
grade 1 or 2
1.43 (1.29-1.57) 2.08 (1.86-2.30)
Left ventricular
grade 3 or 4
5.64 (5.17-6.12) 7.00 (6.14-7.87)
Elective 1.19 (1.03-1.34) 1.90 (1.61-2.18)
Urgent or
emergency
triage status
3.38 (3.12-3.64) 4.39 (3.97-4.81)
CCS class 1 or 2 0.71 (0.52-0.90) 1.30 (0.85-1.74)
CCS class 3 1.24 (1.06-1.42) 1.93 (1.57-2.28)
CCS class 4a 2.77 (2.38-3.15) 3.53 (2.89-4.17)
CCS class 4b 2.75 (2.35-3.15) 3.75 (3.11-4.38)
CCS class 4c 7.02 (6.18-7.86) 9.46 (8.18-10.75)
Values are presented as percentages (95% confidence intervals).
The adjusted mortality rates in this table were calculated by multiplying the
observed to expected death ratio by the average death rate in the cohort
for various subgroups. Expected death was calculated by using 30-day
mortality logistic regression models (excluding the variable being com-
pared).
CABG, Coronary artery bypass graft. CCS, Canadian Cardiovascular Soci-
ety angina class. CCS class 1 or 2 includes patients who are either
asymptomatic or experience a slight limitation of their ordinary activity
caused by angina. CCS class 3 includes patients with a marked limitation
of their ordinary physical activity caused by angina. CCS Class 4a includes
all patients admitted with unstable angina who become pain free with
medical therapy. CCS Class 4b includes all patients admitted with unstable
angina who experience pain with minimal activity despite aggressive medical
therapy. CCS Class 4c includes all patients admitted with unstable angina who
require intravenous treatment or intra-aortic balloon pump insertion to
alleviate anginal symptoms or to maintain hemodynamic stability. early and late crude survival.
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22%, and this is comparable with population-based US
samples, which have ranged between 24% and 28%. There
have been concerns that women compose a minority of
surgical patients because fewer are referred for surgical
intervention. However, many studies have shown that after
their eligibility for an operation is determined through an-
giography, no female referral bias exists if the analysis
27-29
Figure 4. Crude survival curve by sex of patients und
subjects in the general population in Ontario (1991-19
100,000 men and 100,000 women) alive between 1991 an
with the same age and sex distribution as observed
Persons Database contains information on all persons
Figure 5. Risk-adjusted survival curve for patients unde
The numbers of patients that were available in the coh
points after the operation.includes proper risk adjustment. We found that the
The Journal of Thoracicrisk-adjusted 30-day mortality improved over the 1990s,
likely because of improved surgical techniques for both
sexes. This has also been reported by the Northern New
England group.16 Our observation that early mortality was
higher for female patients might have been an artifact of
delayed referral or because female patients are older as a
result of delayed onset of cardiovascular disease.22 It was
surprising to observe that female patients persisted to have
ing isolated CABG surgery and age-matched control
A random sample of Ontario residents (comprised of
9 was selected from the Registered Persons Database
e CABG surgery cohort of this study. The Registered
ntario possessing a valid health card number.
g isolated CABG surgery in Ontario (1991-1999) by sex.
follow are indicated on the graph at the various timeergo
99).
d 199
in th
in Orgoin
ort toa higher early mortality in the current era with improved
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comprehensive risk adjustment.24
Adjustment models were constructed on subcohorts of
patients for whom more data were available to explore this
higher early mortality among female patients further. One of
these variables, socioeconomic status, a known risk factor
for lesser access to cardiac care in Ontario, was used for risk
adjustment in the Cox mortality models.30 Women were
observed to have a significantly lower socioeconomic status
than men. Risk adjustment for socioeconomic status on the
patients with this information available (n  53,702) low-
ered the early 1-year mortality risk (HR decreased from 1.4
to 1.2) for women. We further risk adjusted for BSA on the
subcohort with this variable available (n  13,921) and
found women no longer had a higher early mortality risk
compared with men. Women tended to have a lower body
size, although their distribution of BSA values did overlap
with that of men. In view of this fact, the neutralization of
early mortality by adjustment with BSA might have oc-
curred partially because BSA served as a surrogate marker
for sex. There have been conflicting results in the literature
regarding whether a higher early mortality risk for female
patients remains after adjusting for BSA.2,5,11,15 In sum-
mary, a smaller subcohort of our study demonstrates that
small BSA appears to explain the higher early mortality risk
for female patients. It is evident that this early aspect of
female outcomes still requires further investigation, includ-
ing the evaluation of both biochemical and clinical factors
that might help to explain this difference.
In contrast, the risk-adjusted odds for late mortality
among female patients appeared equivalent to that of male
patients as soon as 1 year after CABG surgery. The previous
Figure 6. Adjusted ORs and 95% CIs for mortality among
surgery in Ontario (1991-1999). The numbers of patients
time points after the operation are indicated on the grstudies looking at long-term mortality involved post hoc
1164 The Journal of Thoracic and Cardiovascular Surgery ● Apranalyses of trials data on patients who were highly selected
with discrete inclusion criteria.21,22 These studies had pa-
tient samples that are not comparable with the older and
sicker patients currently referred for CABG surgery.21,22
The long-term results of our study are similar to those
reported by the Bypass Angioplasty Revascularization In-
vestigation and Coronary Artery Surgery Study trials at 5 to
6 years after surgical intervention.21,22 This is surprising
considering it still appears that women are higher-risk pa-
tients who probably receive fewer arterial grafts with less
complete revascularization. In our cohort women were less
likely to receive an ITA graft compared with men (70% of
female patients vs 79% of male patients, P  .0001).
However, when adjustments were made for ITA use, it did
not change the early or late mortality risk for female sex.
After we adjusted long-term mortality for socioeconomic
status, we found that female sex became a significant pro-
tective factor (HR, 0.94; 95% CI, 0.88-1.00; P  .04).
One of the limitations of our study is that we did not have
detailed operative data on factors that might have differed
for female patients, including coronary artery size and com-
pleteness of revascularization. This type of detailed clinical
information could have helped to explain the higher early
mortality risk experienced by women. Furthermore, other
adverse outcomes, such as nonfatal cardiac events, neuro-
logic complications, or renal insufficiency, might differ
significantly after CABG surgery, and we hope to explore
these questions in future research.
Our study is unique in using interval mortality in the
construction of our regression models rather than cumula-
tive mortality. This approach allowed for tailored assess-
ment with clinical data of those patients who survived to the
ale patients at various time points after isolated CABG
were available in the cohort to follow at the variousfem
that
aph.time interval of interest. Other strengths include the large
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Ontario patients undergoing CABG and the fact that our
study was conducted in the current era, with accurate long-
term follow-up.
From our population of patients undergoing CABG, it
appears that women might have a persistently higher early
mortality in current times but have an excellent late out-
come after CABG surgery. In fact, after further adjustment
for socioeconomic status, female sex might be a protective
factor for long-term survival. Although the long-term ben-
efits of CABG surgery in women are clear, further study is
needed to explore ways to reduce mortality in the periop-
erative period and during the first year after the operation,
particularly in the patients at highest risk, such as those with
the lowest socioeconomic status.
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